FDAFDA · Food and drugs·Recall number D-0958-2017
BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850; By: AstraZeneca AB, SE-151 85 Sodertalje, Sweden, NDC 0186-0777-08.
Published July 19, 2017 · Recall initiated: May 25, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- BRILINTA
- Manufacturer
- AstraZeneca Pharmaceuticals, LP
- Distributor
- Nationwide in the USA and Puerto Rico to physician offices.
- Lot
- Lot # JB5047, Exp 10/19
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.